Meet D CEO Healthcare Panelist Dr. Carlos Arteaga

Dr. Carlos Arteaga will be one of our breakfast panelists on Oct. 18 (Photo courtesy: UT Southwestern).

Next week, D CEO is hosting a healthcare panel to discuss the future of cancer treatment and its implications for the healthcare industry. We are pleased to have renown breast cancer specialist Dr. Carlos Arteaga, the Lisa K. Simmons Distinguished Chair in Comprehensive Oncology at UT Southwestern, as one of our panelists.

Arteaga is known for his work laboratory-based translational research in order to advance the care of breast cancer patients. He has expertise in applying biomedical research conclusions to clinical work, an essential part of advancing cancer care.

Over his 30 year career, he has seen and played a role in increasing the survivorship rates for breast cancer. In an interview with UT Southwestern, Arteaga pointed to a few factors that have contributed to decreased mortality. He notes that early detection and collaborative treatment including surgery, radiation, and chemotherapy have both improved doctor’s ability to fight breast cancer.

While Arteaga wants to be on the cutting edge of technology, he also emphasizes that disparity of care impacts cancer survivor rates as well. Vulnerable communities with compounding health factors often interrupt or overshadow cancer treatment, but he is optimistic about the future of cancer care.

“We’ve made enormous progress,” he told UTSW. “I think that we live in an unprecedented time in the history of cancer care and cancer research. The momentum has never been greater. And I think the next 10 years are going to be transformative in the way we think of cancer, in the way we understand cancer, and in the way we go about treating it. It’s going to be close to unimaginable.”

Arteaga’s medical career has taken from Ecuador to the United States, where he trained at Emory University and UT Health and Science Center. Prior to UTSW, he was physician-scientist in Medical Oncology at the Vanderbilt-Ingram Cancer Center of Vanderbilt University, where he served as Associate Director for Translational/Clinical Research and Director of the Center for Cancer Targeted Therapies.

To hear more from Arteaga and the rest of our panelists, get your tickets to our healthcare breakfast panel on Thursday, Oct. 18. Registration begins at 7 a.m., and the discussion will start at 7:45 a.m. Learn more and buy tickets at the Eventbrite page.